Okubo M, Benson L N, Nykanen D, Azakie A, Van Arsdell G, Coles J, Williams W G
Department of Pediatrics and Surgery, The Hospital For Sick Children, The University of Toronto School of Medicine, Ontario, Canada.
Ann Thorac Surg. 2001 Aug;72(2):416-23. doi: 10.1016/s0003-4975(01)02829-6.
The surgical management of muscular ventricular septal defects (mVSD) in the small infant is a challenge particularly when multiple and associated with complex cardiac lesions. Devices for percutaneous implantation have the advantage of ease of placement and for the double umbrella designs a wide area of coverage. We reviewed our experience and clinical outcomes of intraoperative mVSD device closure for such defects in small infants.
Since October 1989, intraoperative VSD device closure was a component of the surgical strategy in 14 consecutive patient implants (median age, 5.5 months; range, 3 to 11 kg), whose defects were thought difficult to approach using conventional techniques. Nine patients had associated complex cardiac lesions, 10 multiple mVSDs, and 4 patients had a previous pulmonary artery banding.
There were 2 early deaths, 1 in a severely ill child who preoperatively had pulmonary hypertension and left ventricular failure and another in a patient with a hypoplastic left heart. Mean pulmonary to systemic flow ratio before device insertion was 3.5:1. Complete closure was achieved in 5 patients and clinically insignificant residual shunts persisted in 7. In 2 infants with significant residual lesions concomitant pulmonary artery banding was required. Postoperative mean pulmonary to systemic flow ratio was 1.7:1. In follow-up of the 12 surviving infants (mean, 41 months), 8 had complete closure and 3 persistent residual shunts. One patient with no residual shunting required heart transplantation for progressive ventricular failure 9 years after operation. All devices were well positioned on postoperative echocardiograms. There was 1 late death due to aspiration in a patient with a tiny residual shunt.
Infants requiring operative intervention with mVSDs are difficult to manage and have an increased mortality and morbidity. Intraoperative VSD device placement for closure of mVSDs is feasible, can avoid ventriculotomy, division of intracardiac muscle bands, and is ideally suited for the neonate or infant.
小婴儿肌部室间隔缺损(mVSD)的外科治疗是一项挑战,尤其是当缺损为多发且合并复杂心脏病变时。经皮植入装置具有放置简便的优点,对于双伞设计而言,其覆盖面积广。我们回顾了小婴儿此类缺损术中mVSD装置闭合术的经验及临床结果。
自1989年10月起,连续14例患者(年龄中位数5.5个月;范围3至11千克)的术中室间隔缺损装置闭合术成为手术策略的一部分,这些患者的缺损被认为难以用传统技术处理。9例患者合并复杂心脏病变,10例为多发mVSD,4例患者曾行肺动脉环扎术。
有2例早期死亡,1例是术前患有肺动脉高压和左心室衰竭的重症患儿,另1例是左心发育不全的患者。装置植入前平均肺循环与体循环血流量之比为3.5:1。5例实现完全闭合,7例存在临床意义不显著的残余分流。2例有明显残余病变的婴儿需要同期行肺动脉环扎术。术后平均肺循环与体循环血流量之比为1.7:1。在对12例存活婴儿(平均随访41个月)的随访中,8例实现完全闭合,3例仍有持续的残余分流。1例无残余分流的患者在术后9年因进行性心室衰竭需要心脏移植。所有装置在术后超声心动图检查中位置良好。1例有微小残余分流的患者因误吸导致晚期死亡。
需要对mVSD进行手术干预的婴儿治疗困难,死亡率和发病率增加。术中放置VSD装置闭合mVSD是可行的,可避免心室切开、心内肌束切断,非常适合新生儿或婴儿。